| Source:
The Global Evidence tab in the Community-Based Access to Injectable Contraceptives (CBA2I) Toolkit contains a wealth of essential information in support of the practice. This section of the CBA2I Toolkit houses materials from the 2009 WHO technical consultation on CBA2I as well as selected evidence from around the world, including peer-reviewed literature, presentations, and other materials.
- Regions/Countries:
- Global
WHO Upholds Guidance: Women With or at Risk of HIV Can Safely Use Hormonal Methods
WHO released a statement on February 16, 2012, upholding guidance indicating that women with HIV or at high risk of HIV can safely use hormonal contraceptives, including injectables, to prevent pregnancy. However, WHO is instructing health care providers to strongly advise such women who decide to use progestin-only injectables to also always use male or female condoms for protection against HIV. Read more about WHO's statement.
The information provided on this website is not official U.S. Government information and does not represent the views or position
of the U.S. Agency for International Development, the U.S. Government, or The Johns Hopkins University. Read our full Security & Privacy Policies.